CIK 0001645113
- Large accelerated filer
NovoCure Ltd
Sign in to watch- Ticker
- NVCR
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Entity type
- Operating
- Phone
- +44 1534756700
- Business address
- NO. 4 THE FORUM, GRENVILLE STREET, ST. HELIER, Jersey
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $142,786
- in 3 filings
Net −$142,786. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-06-04 | Scannell Timothy J Director | Grant or award · Stock Option (Right to Buy) | +16,697 | 16,697 | ||
| 2025-06-04 | Hung David Director | Grant or award | +11,215 | 23,410 | ||
| 2025-06-04 | Hung David Director | Grant or award · Stock Option (Right to Buy) | +16,697 | 16,697 | ||
| 2025-06-04 | VERNON W ANTHONY Director | Grant or award | +11,215 | 179,102 | ||
| 2025-06-04 | VERNON W ANTHONY Director | Grant or award · Stock Option (Right to Buy) | +16,697 | 16,697 | ||
| 2025-06-04 | Leonard Frank X EVP, Pres., Novocure Oncology | Grant or award | +179,426 | 347,878 | ||
| 2025-06-03 | Stafford Kristin Director | Sale | −999 | $17.28 | $17K | 3,054 |
| 2025-06-03 | LEUNG GABRIEL Director | Sale | −999 | $17.31 | $17K | 81,229 |
| 2025-06-03 | Madden Martin J. Director | Sale | −999 | $17.19 | $17K | 18,674 |
| 2025-06-03 | Scannell Timothy J Director | Sale | −999 | $17.32 | $17K | 6,018 |
| 2025-06-03 | HILLEMAN JERYL L Director | Sale | −999 | $17.26 | $17K | 5,591 |
| 2025-06-03 | Ocean Allyson J Director | Sale | −999 | $17.29 | $17K | 3,054 |
| 2025-06-03 | VERNON W ANTHONY Director | Sale | −999 | $17.35 | $17K | 167,887 |
| 2025-06-03 | Hung David Director | Sale | −999 | $17.30 | $17K | 12,195 |
| 2025-06-02 | Leonard Frank X EVP, Pres., Novocure Oncology | Sale 10b5-1 | −21,717 | $17.22 | $374K | 176,931 |
| 2025-06-02 | Leonard Frank X EVP, Pres., Novocure Oncology | Sale 10b5-1 | −6,600 | $17.99 | $119K | 170,331 |
| 2025-06-02 | Leonard Frank X EVP, Pres., Novocure Oncology | Sale 10b5-1 | −1,879 | $19.01 | $36K | 168,452 |
| 2025-05-03 | Paravasthu Mukund Chief Operating Officer | Sale | −592 | $17.91 | $11K | 83,556 |
| 2025-03-04 | Brackmann Christoph Chief Financial Officer | Grant or award | +54,975 | $18.19 | $1000K | 121,150 |
| 2025-03-04 | Brackmann Christoph Chief Financial Officer | Grant or award · Stock Options (Right to buy) | +81,499 | $18.19 | $1.5M | 81,499 |
Page 6 of 9 · 178 trades